Discover open access scientific publications

Search, annotate, share and cite publications

Publications by K.U. Park

OA10.05 an Open-Label, Multicenter, Phase II Single Arm Trial of Osimertinib in NSCLC Patients With Uncommon EGFR Mutation(KCSG-Lu15-09)

Journal of Thoracic Oncology

Respiratory Medicine

English

Related publications

P2.01-02 Osimertinib for EGFR-Positive Advanced NSCLC With Brain Metastases: Preliminary Analysis of an Open-Label, Two-Arm, Phase 2 Study

Journal of Thoracic Oncology

Respiratory Medicine

English

OA13 High-Dose Icotinib in Advanced NSCLC With EGFR 21 L858R Mutation: A Randomized, Open-Label Phase II Study

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.01-80 ELIOS: A Multicenter, Open-Label, Molecular Profiling Study of Patients With EGFRm and NSCLC Treated With Osimertinib

Journal of Thoracic Oncology

Respiratory Medicine

English

Mocetinostat for Relapsed Classical Hodgkin's Lymphoma: An Open-Label, Single-Arm, Phase 2 Trial

The Lancet Oncology

English

P1.01-47 Phase I/Ii Trial of Dasatinib and Osimertinib in Patients With Advanced EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.11-09 Uncommon EGFR Mutation Analysis From Urine of Lung Cancer Patients

Journal of Thoracic Oncology

Respiratory Medicine

English

Meglumine Antimoniate Intralesional Infiltration for Localised Cutaneous Leishmaniasis: A Single Arm, Open Label, Phase II Clinical Trial

Memorias do Instituto Oswaldo Cruz

English

P1.01-44 Outcome of Uncommon EGFR Mutation Positive Newly Diagnosed Advanced NSCLC Patients: A Single-Centre Retrospective Analysis

Journal of Thoracic Oncology

Respiratory Medicine

English

Infliximab for Pediatric Patients With Ulcerative Colitis: A Phase 3, Open-Label, Uncontrolled, Multicenter Trial in Japan

English